 |
Overview |
 |
|
CDC73
Tumor suppressor probably involved in transcriptional and post-transcriptional control pathways. May be involved in cell cycle progression through the regulation of cyclin D1/PRAD1 expression. Component of the PAF1 complex (PAF1C) which has multiple functions during transcription by RNA polymerase II and is implicated in regulation of development and maintenance of embryonic stem cell pluripotency. PAF1C associates with RNA polymerase II through interaction with POLR2A CTD non- phosphorylated and 'Ser-2'- and 'Ser-5'-phosphorylated forms and is involved in transcriptional elongation, acting both indepentently and synergistically with TCEA1 and in cooperation with the DSIF complex and HTATSF1. PAF1C is required for transcription of Hox and Wnt target genes. PAF1C is involved in hematopoiesis and stimulates transcriptional activity of MLL1; it promotes leukemogenesis though association with MLL-rearranged oncoproteins, such as MLL-MLLT3/AF9 and MLL-MLLT1/ENL. PAF1C is involved in histone modifications such as ubiquitination of histone H2B and methylation on histone H3 'Lys-4' (H3K4me3). PAF1C recruits the RNF20/40 E3 ubiquitin-protein ligase complex and the E2 enzyme UBE2A or UBE2B to chromatin which mediate monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1); UB2A/B-mediated H2B ubiquitination is proposed to be coupled to transcription. PAF1C is involved in mRNA 3' end formation probably through association with cleavage and poly(A) factors. In case of infection by influenza A strain H3N2, PAF1C associates with viral NS1 protein, thereby regulating gene transcription. Connects PAF1C with the cleavage and polyadenylation specificity factor (CPSF) complex and the cleavage stimulation factor (CSTF) complex, and with Wnt signaling. Involved in polyadenylation of mRNA precursors. Component of the PAF1 complex, which consists of CDC73, PAF1, LEO1, CTR9, RTF1 and WDR61. Interacts with POLR2A, CPSF1, CPSF4, CSTF2, MLL and CTNNB1. Interacts with a Set1-like complex that has histone methyltransferase activity and methylates histone H3. Found in a complex with BCL9L or BCL9, CDC73, CTNNB1 and PYGO1 indicative for the participation in a nuclear Wnt signaling complex. Found in adrenal and parathyroid glands, kidney and heart. Belongs to the CDC73 family. Note: This description may include information from UniProtKB.
|
| Protein type: Cell cycle regulation |
|
Cellular Component: nucleus
|
|
Molecular Function: identical protein binding; protein binding
|
|
Biological Process: Wnt receptor signaling pathway; negative regulation of myeloid cell differentiation; endodermal cell fate commitment; protein destabilization; transcription, DNA-dependent; negative regulation of S phase of mitotic cell cycle; histone H2B ubiquitination; stem cell maintenance; positive regulation of mRNA 3'-end processing; mRNA polyadenylation; negative regulation of transcription from RNA polymerase II promoter; cell cycle; histone monoubiquitination; negative regulation of cell proliferation; negative regulation of fibroblast proliferation; positive regulation of RNA elongation from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; positive regulation of Wnt receptor signaling pathway; negative regulation of epithelial cell proliferation
|
|
Reference #:
Q6P1J9 (UniProtKB)
|
| Alt. Names/Synonyms: C1orf28; CDC73; cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae); Cell division cycle protein 73 homolog; FLJ23316; HPTJT; HRPT2; Hyperparathyroidism 2 protein; HYX; Parafibromin |
| Gene Symbols: CDC73 |
|
Molecular weight: 60,577 Da
|
|
Basal Isoelectric point: 9.63
Predict pI for various phosphorylation states
|
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology®
|
|
|
 |
|
Select Structure to View Below |
|
|
CDC73 |
|
|
 |
|
|
|
|
